NPAX for Health Systems
Connect medication, medical, and other available clinical intelligence to identify risk earlier, prioritize meaningful intervention opportunities, and help prevent avoidable ED visits, admissions, and readmissions while supporting patient safety, quality, and financial performance.
NPAX helps health systems act earlier, strengthen patient safety, and improve clinical and financial performance through existing care-delivery workflows.
The Hidden Cost of Medication-Driven Risk
Medication-related problems don't always begin in the hospital. They often develop across fragmented care settings, medication changes, chronic conditions, and transitions between providers.
When these risks go unidentified, the consequences can include avoidable emergency visits, hospitalizations, readmissions, and increased clinical workload.
1.5 Million +
Emergency department visits annually in the United States are associated with adverse drug events.
Source: Centers for Disease Control and Prevention.
Nearly 500,000
People visiting U.S. emergency departments for adverse drug events require hospitalization each year.
Source: Centers for Disease Control and Prevention.
71%
Of adverse drug event-related acute-care admissions evaluated in a published meta-analysis were classified as at least possibly preventable.
Source: Journal of Clinical Medicine, 2023, systematic review and meta-analysis.
When these risks go unidentified, the consequences can include avoidable emergency visits, hospitalizations, readmissions, and increased clinical workload.
Medication Risk Rarely Begins at the Hospital Door.
Patients move between hospitals, specialists, primary care, pharmacies, post-acute care, and home. Along the way, medications change, diagnoses evolve, and treatment decisions are made across disconnected systems.
Even advanced EHRs and clinical decision-support tools may not provide a complete longitudinal picture of medication-driven risk.
NPAX connects medication intelligence with broader medical context to identify clinically meaningful risks that may otherwise remain hidden across transitions of care.
These opportunities may include:
-
Potential adverse drug events and harmful medication interactions
-
Drug-condition conflicts and potentially inappropriate therapies
-
Medication-related risks during care transitions
-
Therapeutic optimization opportunities
-
High-risk medication combinations and vulnerable patients
-
Emerging clinical concerns that warrant pharmacist or care-team review
From reactive treatment to proactive prevention.
NPAX helps health systems recognize risks earlier, prioritize patients who may benefit from intervention, and support informed clinical action before avoidable harm or utilization occurs.
800+ Clinically Vetted Protocols
A broad clinical knowledge base supports the identification and prioritization of medication-related risks and actionable intervention opportunities.
27+ Intervention Types
Multiple intervention approaches allow care teams to respond to identified risks according to clinical relevance and patient need.
AI + Clinical Expertise
Machine learning, rules-based intelligence, and clinical expertise work together to identify meaningful risk patterns and produce understandable insights.
Longitudinal Clinical Context
Connecting medication and medical information helps reveal risks that may be difficult to recognize during isolated patient encounters.
Measurable Clinical and Financial Impact
NPAX supports evaluation of intervention activity, patient outcomes, healthcare utilization, and economic performance.
NPAX Is Here To Help
See What NPAX Could Identify Across Your Patient Population
-
Your organization may already possess the medication and clinical data needed to identify emerging risks that conventional workflows have not yet translated into actionable intelligence.
-
Discover how NPAX can support your clinical teams, help prioritize meaningful interventions, and create opportunities to reduce avoidable utilization while improving patient safety and financial performance.
$0 upfront implementation cost
Shared-savings economics available where appropriate.